BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36004468)

  • 1. [Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting
    Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retracted] MicroRNA‑939‑5p directly targets IGF‑1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway.
    Zhao X; Li J; Yu D
    Int J Mol Med; 2022 Oct; 50(4):. PubMed ID: 36004489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retracted] MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
    Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
    Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retracted] MicroRNA‑511 inhibits malignant behaviors of breast cancer by directly targeting SOX9 and regulating the PI3K/Akt pathway.
    Zhao Y; Pang W; Yang N; Hao L; Wang L
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36043533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] MicroRNA‑432 inhibits the aggressiveness of glioblastoma multiforme by directly targeting IGF‑1R.
    Chen X; Zhang X; Sun S; Zhu M
    Int J Mol Med; 2022 Nov; 50(5):. PubMed ID: 36069216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway.
    Liu Y; Wang Y; Yang H; Zhao L; Song R; Tan H; Wang L
    Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36102301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma.
    Wang Q; Wang J; Niu S; Wang S; Liu Y; Wang X
    Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retracted] miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1.
    Zhang J; Li J; Li S; Zhou C; Qin Y; Li X
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35796016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retracted] MicroRNA‑448 inhibits the progression of retinoblastoma by directly targeting ROCK1 and regulating PI3K/AKT signalling pathway.
    Wu S; Ai N; Liu Q; Zhang J
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35730602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retracted] MicroRNA‑655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways.
    Zhang M; Li Q; Pan Y; Wang H; Liu G; Yin H
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 35946459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retracted] Downregulation of microRNA‑198 suppresses cell proliferation and invasion in retinoblastoma by directly targeting PTEN.
    Wei D; Miao Y; Yu L; Wang D; Wang Y
    Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 36004487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retracted] Silencing the long noncoding RNA,
    Li R; Wang Y; Xu Y; He X; Li Y
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36004482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retracted] MicroRNA‑874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin.
    Zhang Y; Wang X; Zhao Y
    Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36416339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retracted] MicroRNA‑760 inhibits cell proliferation and invasion of colorectal cancer by targeting the SP1‑mediated PTEN/AKT signalling pathway.
    Li X; Ding Y; Liu N; Sun Q; Zhang J
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35762320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retracted] MicroRNA‑122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.
    Xu Q; Zhang M; Tu J; Pang L; Cai W; Liu X
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36601771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retracted] MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Liu X; Wang Y; Zhao J
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36043516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retracted] MicroRNA‑202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin.
    Yang J; Fan B; Zhao Y; Fang J
    Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35674173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retracted] MicroRNA‑379 inhibits cell proliferation and invasion in glioma via targeting metadherin and regulating PTEN/AKT pathway.
    Li L; Zhang H
    Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36102295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] MicroRNA‑874 inhibits proliferation and invasion of pancreatic ductal adenocarcinoma cells by directly targeting paired box 6.
    Diao J; Su X; Cao L; Yang Y; Liu Y
    Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36263599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retracted] MicroRNA‑197 inhibits gastric cancer progression by directly targeting metadherin.
    Liao Z; Li Y; Zhou Y; Huang Q; Dong J
    Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35674191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.